Suppl Figure Legends from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant

Authors :: Shiuan Chen
Joanne Mortimer
Laura Kruper
Courtney A. Vito
Peiguo Chu
Hannah Lu
Chun-Yu Liu
Masaya Kai
Daniel Schmolze
Duc Nguyen
Hang-Kai Hsu
Karineh Petrossian
Noriko Kanaya
Victoria Shang Wu
Pei-Yin Hsu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Suppl Figure Legends

Tools